Merz Therapeutics GmbH

Merz Therapeutics Germany, headquartered in Frankfurt am Main, is the strategic and operational heart of Merz Therapeutics. As part of the Merz Group, it leads the development, production, and commercialization of innovative specialty pharmaceuticals, with a focus on neurological disorders, movement conditions, and hepatological and dermatological indications. From Frankfurt, we drive global strategy, research, and portfolio expansion – most recently with new treatments for Parkinson’s disease and multiple sclerosis – while maintaining long-term independence through our owner-managed structure.